---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018725"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2025-10-21T23:59:59+00:00"
generated_at: "2026-05-17T02:57:58.790638+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Oragenics settles Ladenburg dispute for $700K; regains NYSE American compliance

## Summary
- Paid $700K to Ladenburg Thalmann to settle $2.5M fee dispute; mutual release and arbitration dismissal.
- Regained compliance with NYSE American Section 1003(a) as stockholders' equity exceeds $6M as of Oct 18, 2025.
- Compliance restored after $16.5M Series H Preferred Stock offering in July 2025; .BC indicator to be removed.
- Company now focusing on advancing ONP-002 concussion treatment into Phase IIa trials in Australia and planning U.S. Phase IIb.

## SEC filing metadata
- accession: 0001493152-25-018725
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2025-10-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315225018725/0001493152-25-018725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315225018725/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018725
- JSON: https://secwatch.observer/filing/0001493152-25-018725.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.